Commercial · PA
Highmark
Highmark publishes coverage policies for 4 of the 4 sleep apnea treatments we track. Each is linked to its source document below.
By treatment
CPAP and PAP therapy
Policy publishedOral appliance therapy
Policy publishedPolicy number — E-20-038
Effective — 2023-10-01
Published utilization-management detail
- CPAP trial failed or CPAP is contraindicated
Hypoglossal nerve stimulation
Policy publishedPolicy number — S-280-003
Effective — 2024-09-30
Published utilization-management detail
- Documented PAP failure or intolerance
Tirzepatide (Zepbound) for OSA
Policy publishedPolicy number — J-1388-013
Effective — 2025-08-26
Published utilization-management detail
- For the published Delaware commercial OSA pathway, the member must be compliant with PAP or have failed/cannot use PAP and then be adherent to a custom oral appliance, along with other policy requirements.
Last verified 2026-08-15. We record structured facts and link the source; we do not reproduce policy text. The document itself governs.
If you're denied
Highmark publishes its own appeal instructions. Start there, and note the deadline on your denial letter.
Your specific plan may differ from Highmark's general policy, particularly if your coverage is through an employer. Policies are revised without notice. Nothing here is a guarantee of coverage or a substitute for confirming with your plan.